Schedule of Purchase Price Allocated to Acquired Assets (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 09, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Asset Acquisition [Line Items] | |||
| Cash payment | $ 1,500 | ||
| Sequence LifeScience Inc [Member] | |||
| Asset Acquisition [Line Items] | |||
| Cash payment | $ 1,500 | ||
| Contingent consideration | 650 | ||
| Total consideration | 2,150 | ||
| Inventory | 2,150 | ||
| Total assets acquired | $ 2,150 | ||
| X | ||||||||||
- Definition Asset acquisition recognized identifiable assets acquired and liabilities assumed inventory assets. No definition available.
|
| X | ||||||||||
- Definition Asset acquisition recognized identifiable assets acquired and liabilities assumed inventory. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of contingent consideration recognized as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|